<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7369591\results\search\zoonosis\results.xml">
  <result pre="severe acute respiratory syndrome coronavirus 2, the causal agent of" exact="coronavirus disease 2019" post="(COVID-19), quickly spread around the world, resulting in the"/>
  <result pre="landscape for promising therapies is described. Abbreviations and Acronyms COVID-19," exact="coronavirus disease 2019" post="CPT, convalescent plasma therapy CQ, chloroquine EC50, half-maximal effective"/>
  <result pre="unit IL-6, interleukin 6 JAK, Janus kinase LPV/RTV, lopinavir/ritonavir MERS," exact="Middle East respiratory syndrome" post="RCT, randomized controlled trial SARS, severe acute respiratory syndrome"/>
  <result pre="WHO, World Health Organization Article Highlights â€¢Most emerging therapies for" exact="coronavirus disease 2019" post="have antiviral activity for addressing infection directly or counteract"/>
  <result pre="severe disease. â€¢The currently available clinical evidence for promising emerging" exact="coronavirus disease 2019" post="therapies provides rationale for continued investigation but is inconclusive"/>
  <result pre="respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), the causal agent of" exact="coronavirus disease 2019" post="(COVID-19), appeared in December 2019 in Wuhan, China, and"/>
  <result pre="and drugs that were used for similar diseases including SARS," exact="Middle East respiratory syndrome" post="(MERS), and Ebola have emerged as treatment options because"/>
  <result pre="similar diseases including SARS, Middle East respiratory syndrome (MERS), and" exact="Ebola" post="have emerged as treatment options because of their known"/>
  <result pre="112 Transfer of humoral immunity Antiâ€&quot;SARS-CoV-2 humoral immunity aCOVID-19Â =" exact="coronavirus disease 2019;" post="SARS-CoV-2Â = severe acute respiratory distress syndrome coronavirusÂ 2."/>
  <result pre="of viral replication and RNA synthesis.8,9 Data supporting treatment of" exact="SARS-CoV-2 infection" post="with remdesivir include established potency against coronaviruses inÂ vitro8"/>
  <result pre="Single 0 (0) Multi 1 (8) Other 838 aCOVID-19 =" exact="coronavirus disease 2019;" post="SARS-CoV-2 = severe acute respiratory distress syndrome coronavirus 2;"/>
  <result pre="a WHO-sponsored, adaptive RCT open to any patient with confirmed" exact="SARS-CoV-2 infection" post="worldwide. On the basis of institutional drug availability, patients"/>
  <result pre="21, 28, and 60-d mortality Convalescent Plasma as Therapy for" exact="Covid-19" post="Severe SARS-CoV-2 Disease (CONCOVID Study) (ClinicalTrials.gov identifier: NCT04342182) The"/>
  <result pre="until hospital discharge or 60-dHospital length of stay COVID-19Â =" exact="coronavirus disease 2019;" post="CQ/HCQÂ = chloroquine or hydroxychloroquine; FiO2Â = fraction of"/>
  <result pre="29, 2020 3DengY.LiuW.LiuK.Clinical characteristics of fatal and recovered cases of" exact="coronavirus disease 2019" post="(COVID-19) in Wuhan, China: a retrospective studyChin Med J"/>
  <result pre="TeamClinical and virologic characteristics of the first 12 patients with" exact="coronavirus disease 2019" post="(COVID-19) in the United StatesNat Med266202086186832327757 18AntinoriS.CossuM.V.RidolfoA.L.Compassionate remdesivir treatment"/>
  <result pre="in the United StatesNat Med266202086186832327757 18AntinoriS.CossuM.V.RidolfoA.L.Compassionate remdesivir treatment of severe" exact="Covid-19" post="pneumonia in intensive care unit (ICU) and non-ICU patients:"/>
  <result pre="InvestigatorsRemdesivir for 5 or 10 days in patients with severe" exact="Covid-19" post="[published online ahead of print May 27, 2020]N Engl"/>
  <result pre="respiratory syndromeAntivir Ther215201645545926492219 28SpanakisN.TsiodrasS.HaagmansB.L.Virological and serological analysis of a recent" exact="Middle East respiratory syndrome" post="coronavirus infection case on a triple combination antiviral regimenInt"/>
  <result pre="trialTrials19120188129382391 30WangZ.ChenX.LuY.ChenF.ZhangW.Clinical characteristics and therapeutic procedure for four cases with" exact="2019 novel coronavirus pneumonia" post="receiving combined Chinese and Western medicine treatmentBiosci Trends1412020646832037389 31YoungB.E.OngS.W.X.KalimuddinS.collab:"/>
  <result pre="Biol124202032232532236562 41SchoergenhoferC.JilmaB.StimpflT.KarolyiM.ZoufalyA.Pharmacokinetics of lopinavir and ritonavir in patients hospitalized with" exact="coronavirus disease 2019" post="(COVID-19) [published online ahead of print May 12, 2020]Ann"/>
  <result pre="Wuhan, ChinaLancet39510223202049750631986264 44ChenN.ZhouM.DongX.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive studyLancet39510233202050751332007143 45WanS.YiQ.FanS.Characteristics of lymphocyte"/>
  <result pre="and cytokines in peripheral blood of 123 hospitalized patients with" exact="2019 novel coronavirus pneumonia" post="(NCP) [published online ahead of print February 12, 2020]medRxivhttps://doi.org/10.1101/2020.02.10.20021832"/>
  <result pre="with COVID-19 in Wuhan, ChinaClin Infect Dis7115202076276832161940 48ShiY.TanM.ChenX.Immunopathological characteristics of" exact="coronavirus disease 2019" post="cases in Guangzhou, China [published online ahead of print"/>
  <result pre="REgistry (SMACORE)Microorganisms852020695 61MarfellaR.PaolissoP.SarduC.Negative impact of hyperglycaemia on tocilizumab therapy in" exact="Covid-19" post="patients [published online ahead of print May 21, 2020]Diabetes"/>
  <result pre="print June 24, 2020]J Infecthttps://doi.org/10.1016/j.jinf.2020.06.052 65CaoY.WeiJ.ZouL.Ruxolitinib in treatment of severe" exact="coronavirus disease 2019" post="(COVID-19): a multicenter, single-blind, randomized controlled trialJÂ Allergy Clin"/>
  <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="inÂ vitroCell Discov620201632194981 78YaoX.YeF.ZhangM.InÂ vitro antiviral activity and projection"/>
  <result pre="pharmacokinetically guided dosing for investigational treatments of pediatric patients with" exact="coronavirus disease 2019" post="[published online ahead of print June 5, 2020]JAMA Pediatrhttps://doi.org/10.1001/jamapediatrics.2020.2422"/>
 </snippets>
</snippetsTree>
